Protinhi Therapeutics
We are an early-stage biotech company aiming to combat (emerging) viral infectious diseases with a high unmet medical need via protease inhibition. With our proprietary technology platform, we are actively developing novel antiviral drugs that inhibit proteases and block viral replication. We aim for easy-to-administer drugs able to treat in epidemic and pandemic situations.
Sign up for Protinhi Newsletter
Subscribe to Protinhi Newsletter to stay tuned for the latest updates on our news, activities, achievements, and more.
